128 related articles for article (PubMed ID: 38636399)
1. Iguratimod inhibits protein citrullination and inflammation by downregulating NBCe2 in patients with rheumatoid arthritis.
Peng T; Li B; Bi L; Zhang F
Biomed Pharmacother; 2024 May; 174():116551. PubMed ID: 38636399
[TBL] [Abstract][Full Text] [Related]
2. Iguratimod dose dependently inhibits the expression of citrullinated proteins and peptidylarginine deiminases 2 and 4 in neutrophils from rheumatoid arthritis patients.
Li B; Li P; Bi L
Clin Rheumatol; 2020 Mar; 39(3):899-907. PubMed ID: 31758423
[TBL] [Abstract][Full Text] [Related]
3. Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14
Okamato Y; Ghosh T; Okamoto T; Schuyler RP; Seifert J; Charry LL; Visser A; Feser M; Fleischer C; Pedrick C; August J; Moss L; Bemis EA; Norris JM; Kuhn KA; Demoruelle MK; Deane KD; Ghosh D; Holers VM; Hsieh EWY
J Autoimmun; 2021 Feb; 117():102581. PubMed ID: 33310262
[TBL] [Abstract][Full Text] [Related]
4. Local administration of glucocorticoids decreases synovial citrullination in rheumatoid arthritis.
Makrygiannakis D; Revu S; Engström M; af Klint E; Nicholas AP; Pruijn GJ; Catrina AI
Arthritis Res Ther; 2012 Jan; 14(1):R20. PubMed ID: 22284820
[TBL] [Abstract][Full Text] [Related]
5. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
Front Immunol; 2021; 12():716250. PubMed ID: 34737738
[TBL] [Abstract][Full Text] [Related]
6. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
[TBL] [Abstract][Full Text] [Related]
7. Peptidylarginine deiminase 2, 3 and 4 have distinct specificities against cellular substrates: novel insights into autoantigen selection in rheumatoid arthritis.
Darrah E; Rosen A; Giles JT; Andrade F
Ann Rheum Dis; 2012 Jan; 71(1):92-8. PubMed ID: 21859690
[TBL] [Abstract][Full Text] [Related]
8. Clinical effectiveness of iguratimod based on real-world data of patients with rheumatoid arthritis.
Mizutani S; Kodera H; Sato Y; Nanki T; Yoshida S; Yasuoka H
Clin Rheumatol; 2021 Jan; 40(1):123-132. PubMed ID: 32506311
[TBL] [Abstract][Full Text] [Related]
9. Citrullinated inter-alpha-trypsin inhibitor heavy chain 4 in arthritic joints and its potential effect in the neutrophil migration.
Osada A; Matsumoto I; Mikami N; Ohyama A; Kurata I; Kondo Y; Tsuboi H; Ishigami A; Sano Y; Arai T; Ise N; Sumida T
Clin Exp Immunol; 2021 Mar; 203(3):385-399. PubMed ID: 33238047
[TBL] [Abstract][Full Text] [Related]
10. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
11. Iguratimod Inhibits the Aggressiveness of Rheumatoid Fibroblast-Like Synoviocytes.
Lin J; Yu Y; Wang X; Ke Y; Sun C; Yue L; Xu G; Xu B; Xu L; Cao H; Xu D; Olsen N; Chen W
J Immunol Res; 2019; 2019():6929286. PubMed ID: 31828173
[TBL] [Abstract][Full Text] [Related]
12. Neuroinflammation and histone H3 citrullination are increased in X-linked Dystonia Parkinsonism post-mortem prefrontal cortex.
Petrozziello T; Mills AN; Vaine CA; Penney EB; Fernandez-Cerado C; Legarda GPA; Velasco-Andrada MS; Acuña PJ; Ang MA; Muñoz EL; Diesta CCE; Macalintal-Canlas R; Acuña-Sunshine G; Ozelius LJ; Sharma N; Bragg DC; Sadri-Vakili G
Neurobiol Dis; 2020 Oct; 144():105032. PubMed ID: 32739252
[TBL] [Abstract][Full Text] [Related]
13. PAD enzymes in rheumatoid arthritis: pathogenic effectors and autoimmune targets.
Curran AM; Naik P; Giles JT; Darrah E
Nat Rev Rheumatol; 2020 Jun; 16(6):301-315. PubMed ID: 32341463
[TBL] [Abstract][Full Text] [Related]
14. Identification of potential autoantigens in anti-CCP-positive and anti-CCP-negative rheumatoid arthritis using citrulline-specific protein arrays.
Poulsen TBG; Damgaard D; Jørgensen MM; Senolt L; Blackburn JM; Nielsen CH; Stensballe A
Sci Rep; 2021 Aug; 11(1):17300. PubMed ID: 34453079
[TBL] [Abstract][Full Text] [Related]
15. Insight into Neutrophil Extracellular Traps through Systematic Evaluation of Citrullination and Peptidylarginine Deiminases.
Holmes CL; Shim D; Kernien J; Johnson CJ; Nett JE; Shelef MA
J Immunol Res; 2019; 2019():2160192. PubMed ID: 30993117
[TBL] [Abstract][Full Text] [Related]
16. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
[TBL] [Abstract][Full Text] [Related]
17. Generation of Distinct Patterns of Rheumatoid Arthritis Autoantigens by Peptidylarginine Deiminase Types 2 and 4 During Perforin-Induced Cell Damage.
Romero V; Darrah E; Andrade F
Arthritis Rheumatol; 2020 Jun; 72(6):912-918. PubMed ID: 31876120
[TBL] [Abstract][Full Text] [Related]
18. The three-year efficacy of iguratimod in clinical daily practice in patients with rheumatoid arthritis.
Suto T; Yonemoto Y; Okamura K; Sakane H; Takeuchi K; Tamura Y; Kaneko T; Ayabe K; Chikuda H
Mod Rheumatol; 2019 Sep; 29(5):775-781. PubMed ID: 30092680
[No Abstract] [Full Text] [Related]
19. A novel disease-modifying antirheumatic drug, iguratimod, ameliorates murine arthritis by blocking IL-17 signaling, distinct from methotrexate and leflunomide.
Luo Q; Sun Y; Liu W; Qian C; Jin B; Tao F; Gu Y; Wu X; Shen Y; Xu Q
J Immunol; 2013 Nov; 191(10):4969-78. PubMed ID: 24123677
[TBL] [Abstract][Full Text] [Related]
20. Effects of vitamin K
Xu W; Wu H; Tahara K; Chen S; Wang X; Tanaka S; Sugiyama K; Sawada T; Hirano T
Fundam Clin Pharmacol; 2021 Oct; 35(5):832-842. PubMed ID: 33780033
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
